Development and validation a nomogram for predicting the risk of severe COVID-19: A multi-center study in Sichuan,

Yiwu Zhou1,2, Yanqi He3, Huan Yang3

  • 1Department of Emergency Medicine, Emergency Medical Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Plos One
|May 19, 2020
PubMed

Insights

This study developed a nomogram to predict severe coronavirus disease 2019 (COVID-19) risk using clinical data. The model effectively identifies patients at high risk for severe outcomes.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Medical Informatics

Background:

  • Coronavirus disease 2019 (COVID-19) rapidly spread globally since December 2019.
  • Accurate risk stratification for severe COVID-19 is crucial for patient management.

Purpose of the Study:

  • To develop and validate a practical nomogram for predicting the risk of severe COVID-19.
  • To identify key clinical predictors for severe disease progression.

Main Methods:

  • A cohort of 366 COVID-19 patients was analyzed.
  • Least Absolute Shrinkage and Selection Operator (LASSO) regression and multivariable logistic regression were used.
  • Internal validation was performed using bootstrapping.

Main Results:

  • The nomogram incorporated seven predictors: body temperature, cough, dyspnea, hypertension, cardiovascular disease, chronic liver disease, and chronic kidney disease.
  • The model demonstrated good discrimination (C-index: 0.863) and calibration.
  • Internal validation yielded a C-index of 0.839, indicating clinical usefulness.

Conclusions:

  • An early warning model for severe COVID-19 was established using readily available admission clinical characteristics.
  • This nomogram aids in predicting severe COVID-19 and identifying at-risk patients.
Abstract